- Home
- APLT vs NXGL Comparison
APLT vs NXGL Comparison
Compare APLT & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLT | NXGL |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 15.0M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | APLT | NXGL |
|---|---|---|
| Price | $0.10 | $1.61 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.25 | N/A |
| AVG Volume (30 Days) | ★ 11.6M | 43.3K |
| Earning Date | 11-13-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,000,000.00 | ★ $11,666,000.00 |
| Revenue This Year | $124.18 | $39.28 |
| Revenue Next Year | $25.00 | $42.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 73.37 |
| 52 Week Low | $0.09 | $1.45 |
| 52 Week High | $1.50 | $4.00 |
Technical Indicators
Market Signals| Indicator | APLT | NXGL |
|---|---|---|
| Relative Strength Index (RSI) | 28.21 | 45.56 |
| Support Level | $0.09 | $1.65 |
| Resistance Level | $0.10 | $1.78 |
| Average True Range (ATR) | 0.01 | 0.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 34.74 | 37.50 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.